Nourica is a European MedTech startup founded in 2022, based in Poland. The company's mission is to develop innovative devices for non-invasive health biomarker testing from human sweat. Their slogan, "Non-invasive health biomarkers diagnostics from human sweat," emphasizes their focus on non-invasive diagnostic solutions.
Utilizing state-of-the-art spectroscopic technology, Nourica has designed diagnostic devices that can extract and analyze biomarkers from human sweat. This approach provides a convenient and reliable solution for disease screening, health monitoring, and dietary adjustments, addressing significant needs within the Health Care industry.
The startup recently secured a $250.00K pre-seed round investment on 20 December 2022 from Scanderia Venture, showcasing early investor confidence in their innovative approach to health diagnostics. With this support, Nourica is well-positioned to advance their technology and expand their market presence, potentially disrupting traditional health diagnostic methods and making significant contributions to the MedTech industry.
No recent news or press coverage available for Nourica.